MR imaging of the breast for the detection, diagnosis, and staging of breast cancer

Radiology

Volumn 220, Issue 1, 2001, Pages 13-30

  Orel, S G ^a   Schnall, M D ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast neoplasm, MR, 00.121411, 00.121412, 00.121415, 00.12143; Breast neoplasms, diagnosis, 00.31, 00.32, 00.81; Breast neoplasms, staging; Breast, MR, 00.121411, 00.121412, 00.121415, 00.12143; State of the Art

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; CANCER STAGING; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0034972373     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.220.1.r01jl3113     Document Type: Article

References (114)

1. Contrastenhanced magnetic resonance imaging of the breast
2. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA - Preliminary observations
3. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
4. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
5. MR characterization of suspicious breast lesions with a gadolinium-enhanced turboFLASH subtraction technique
6. Contrast-enhanced magnetic resonance imaging of the breast
7. Nonpalpable breast tumors: Diagnosis with contrast-enhanced subtraction dynamic MR imaging
8. MR imaging of the breast with Gd-DTPA: Use and limitations
9. Breast disease evaluation with fat-suppressed magnetic resonance imaging
10. Gadopenetate dimeglumine-enhanced chemical-shift MR imaging of the breast
11. Imaging techniques for breast MR imaging
12. Breast cancer: Gadolinium-enhanced MR imaging with a 0.5-T open imager and three-point Dixon technique
13. Multicoil array for high resolution imaging of the breast
14. Design and optimization of a breast coil for magnetic resonance imaging
15. Technical aspects of breast magnetic resonance imaging
16. Contrast-enhanced MR imaging of the breast: Comparison of two different doses of gadopentetate dime-glumine
17. A comparison of fast scan techniques for breast imaging
18. Fibroadenomas: MR imaging appearances with radiologic-histologic correlation
19. Benign and malignant breast lesions: Differentiation with echo-planar MR imaging
20. Dynamic echo-planar imaging of the breast: Experience in diagnosing breast carcinoma and correlation with tumor angiogenesis
21. Pharmacokinetic analysis of breast disease with dynamic spiral MRI
22. Dynamic three-dimensional imaging with partial k-space sampling: Initial application for gadolinium-enhanced rate characterization of breast lesions
23. Bilateral imaging using separate interleaved 3D volumes and dynamically switched multiple receive coil arrays
24. Inversion in the steady state: Contrast optimization and reduced imaging time with fast three-dimensional inversion-recovery-prepared GRE pulse sequences
25. MR imaging-guided breast intervention: Experience with two systems
26. MR-guided biopsy of suspect breast lesions with a simple stereotaxic add-on device for surface coils
27. Optimal procedure and coil design for MR imaging-guided transcutaneous needle localization and biopsy
28. MR mammographic localizations: Work in progress
29. Interventional breast MR imaging: Clinical use of stereotactic localization and biopsy device
30. MR imaging-guided localization and biopsy of breast lesions: Initial experience
31. Prototype breast coil for MR guided needle localization
32. Breast lesion localization: A free-hand interactive MR imaging technique
33. High-resolution MR imaging of the breast: Clinical context
34. MR-guided percutaneous vacuum biopsy of breast lesions: Experiences with 100 lesions
35. Breast disease: Tissue characterization with Gd-DTPA enhancement profiles
36. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast-enhanced MRI
37. The indeterminate breast mass: Assessment using contrast-enhanced magnetic resonance imaging
38. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency
39. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
40. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features
41. Gadolinium-enhanced breast MRI
42. Dynamic 3D-MR mammography: Is there a benefit of sophisticated evaluation of enhancement curves for clinical routine?
43. Dynamic MRI of invasive breast cancer: Assessment of three region-of-interest analysis methods
44. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography
45. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: Are time-signal intensity, curves an accurate predictor?
46. MR imaging of ductal carcinoma in situ
47. Patterns of peripheral enhancement in breast masses: Correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis
48. Breast lesions: Correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis
49. Peripheral washout sign on contrast-enhanced MR images of the breast
50. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ
51. Ductal carcinoma in situ: MR imaging - Histopathologic correlation
52. Fibroadenomas: Histopathologic and MR imaging features
53. Breast MR imaging: Interpretation model
54. Technical report of the International Working Group on Breast MRI
55. Improved diagnostic accuracy in dynamic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis
56. Preoperative imaging-guided needle placement and localization of clinically occult lesions
57. False-positive cases in dynamic MR mammography
58. Breast MR imaging with commercially available techniques: Radiologic-pathologic correlation
59. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast
60. Menstrual cycle and age: Influence of parenchymal contrast medium enhancement in MR imaging of the breast
61. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia
62. The status of mammographically guided fine needle aspiration biopsy of non-palpable breast lesions
63. Cost-effectiveness of stereotactic core needle biopsy: Analysis by means of mammographic findings
64. US-guided automated large-core breast biopsy
65. Non-palpable breast lesions: Stereotactic automated large-core biopsies
66. Impact of stereotaxic core biopsy on cost of diagnosis
67. MR imaging in the management before surgery of lobular carcinoma of the breast: Correlation with pathology
68. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent
69. MR imaging of the breast in patients with invasive lobular carcinoma
70. Breast cancer diagnosis with MR imaging: Effect of clinical and mammographic findings on recommendations for biopsy
71. MR imaging of mammographically detected clustered microcalcifications: Is there any value?
72. What is the evidence that tumors are angiogensis dependent?
73. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
74. Microvessel density and distribution in ductal carcinoma in situ of the breast
75. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram
76. High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer
77. Effect of temporal resolution on the diagnostic efficacy of contrast-enhanced MRI in the conservatively treated breast
78. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast
79. Tumor recurrence versus fibrosis in the irradiated breast: Differentiation with dynamic gadolinium-enhanced MR imaging
80. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: Preliminary results in 26 patients
81. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy
82. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma
83. Comparison of magnetic resonance imaging and conventional triple assessment in locally recurrent breast cancer
84. Assessment of local recurrence after breast-conserving therapy with MRI
85. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma
86. Delayed development of enhancement in fat necrosis after breast conservation therapy: A potential pitfall of MR imaging of the breast
87. MR imaging of the breast after surgery for breast cancer
88. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy
89. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: Detection with MR imaging
90. Utility of magnetic resonance imaging in the management of breast cancer: Evidence for improved preoperative staging
91. Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach
92. Staging of symptomatic primary breast cancer with MR imaging
93. Breast carcinoma: MR imaging before re-excisional biopsy
94. Detection with MR imaging of residual tumor in the breast soon after surgery
95. Special considerations
96. MR imaging of the breast in patients with occult primary breast carcinoma
97. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy
98. MRI of the breast in patients with metastatic disease of unknown primary
99. MRI in patients with axillary metastases of occult breast carcinoma
100. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
101. Multimodal therapy in locally advanced breast carcinoma
102. Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy
103. MRI of breast cancer: Influence of chemotherapy on sensitivity
104. Laser therapy for breast cancer: MR imaging and histopathologic correlation
105. Integration of breast magnetic resonance imaging with breast cancer treatment
106. Treatment of breast disease
107. Occult contralateral breast cancer detected by breast MR
108. Assessment and counseling for women with a family history of breast cancer
109. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
110. Autosomal dominant inheritance of early onset breast cancer
111. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
112. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: Preliminary results